Table 2 Percentage of positive antibody detections via competitive ELISA (for the generic detection of antibodies to AIV nucleoprotein) and via haemagglutination inhibition assay and/or ELISA (for the detection of H5, H13 and H16 subtype-specific AIV antibodies) for individuals of each species.
Species | cELISA (H1-H16) | H5 HI | H13 HI | H16 HI | H5 ELISA | Antibody co-occurrence |
---|---|---|---|---|---|---|
Shag | 1.1% (1/87) | 0% (0/92) | Not tested* | Not tested* | 100% (1/1) | |
Kittiwake | 78.7% (48/61) | 0% (0/69) | 19.0% (4/21) | 95.2% (20/21) | 0% (0/39) | H16 + H13 (n = 4) |
Razorbill | 31.9% (15/47) | 0% (0/44) | 0% (0/13) | 30.8% (4/13) | 7.7% (1/13) | H5 + H16 (n = 1) |
Guillemot | 41.3% (19/46) | 2.4% (1/42) | 0% (0/15) | 0% (0/15) | 33.3% (6/18) | |
Puffin | 36.4% (16/44) | 0% (0/42) | 0% (0/13) | 0% (0/13) | 7.7% (1/13) |